approval · primary record
ARGATROBAN
FDA · NDA · 2026-06-26
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-06-26 |
| Brand | ARGATROBAN IN 0.9% SODIUM CHLORIDE |
| Sponsor | TEVA PHARMS USA |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:15.514Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ARGATROBAN:2026-06-26
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Argatroban · compound